The paper "Biotechnology Industry - the United States of America Department of Agriculture" is a perfect example of an agriculture case study. This report focuses is based on critical appraisal. This is the appraisal of the lab to market transition undertaken by one of the industries in the biotechnology field. Generally, it focuses on the commercialization process. This report also provides a synthesis of different elements involved in the commercialization process that concern the scientific R$D, business/product development, funding regimes and intellectual property strategies. The biotechnology industry under discussion is animal cloning.
This is under the scrutiny of USDA. USDA stands for United States of America Department of Agriculture. The innovative commercialization process here is the lab to the market transition of animal cloning. Introduction The introduction focuses on the general case. It also looks into the historical outline of the animal cloning industry, noteworthy developments and its growth over the years. Before talking of the transition, however, looking into commercialization briefly is noteworthy. Commercialization entails the introduction of a new product into the market. It also involves introducing a new production method in the market.
What is taking place in the company is a transition from the lab system to the market system. There is the introduction of the market system to replace the lab system. The actual launch of the new product into the market acts as the final stage of the new product development. The company under discussion is an animal cloning company. Cloning falls under both biotechnology and technology. Cloning animals does not in any way require genetic modification like biotechnology. It leads to the production of twins and not altered animals.
Animal clones begin their lives in the laboratory. This is where their embryos are implanted and later on born in the usual way. Invention and Innovation Cloning is not new to people. Plants have been cloned for many decades. However, the process of cloning plants is called vegetative propagation. Most pears, peaches, potatoes, bananas, grapes and apples come from the cloning process. Livestock clowning originates from 1996. It has since then acted as the forward step in assisting with reproductive technology. This is the type of technology that has surpassed embryo transfer, in vitro fertilization and artificial insemination (E, 2000). Several other companies that deal with animal cloning have gone private.
USDA has however not been involved heavily in scientific oversight of animal cloning. It is necessary to clearly articulate the strategic issues that the company has faced. This is in regard to the commercialization process. Transition plan from lab to market is vital for the animal cloning company. Currently, there are close to 600 animal clones. Most of them are beef cattle. It is however unlikely that they will head to the market.
This is because they are highly expensive in production (Brizek, 2009). They are however being put to use as breeding livestock. They help in the transition of their exceptional qualities to their offspring. A voluntary moratorium for any clones in the food supply is however continual. Opportunity Recognition Any sexually reproduced offspring of any clones are animals that will end up winding up in the meat case or in producing milk in many dairy counters. The moratorium has therefore been lifted for any of these animals. The role of USDA therefore in the transition will be in facilitating the smooth and orderly transition.
This is helpful so that technology producers, providers, retailers, processors and international and domestic customers come together. This way they can work together like milk and meat from animal clones and their own offspring’ s become available in the market (Onyeka, 2011).
Aggarwal, V. A. (2009). Strategic Management Journal. Modes of cooperative R&D commercialization by start-ups , 835-864.
Bren, L. (2007). FDA Consumer. Animal Cloning and Food Safety , 32-35.
Brizek, M. G. (2009). Journal of Academic & Business Ethics. Food cloning - ethical considerations for business organizations , 1-12.
E, P. (2000). Science. Animal cloning. Clones: a hard act to follow , 1722-1777.
Edwards, J. L. (2003). American Journal of Reproductive Immunology. Cloning Adult Farm Animals: A Review of the Possibilities and Problems Associated with Somatic Cell Nuclear Transfer , 113-123.
Haeussler, C. (2011). Entrepreneurship: Theory & Practice. The Determinants of Commercialization Strategy: Idiosyncrasies in British and German Biotechnology , 653-681.
Laible, G. (2007). New Zealand Journal of Agricultural Research. Recent advances and future options for New Zealand agriculture derived from animal cloning and transgenics , 103-124.
Mensing, B. M. (2010). Sustainable Development Law & Policy. LIVESTOCK ANIMAL CLONING: THIS STEAK IS GIVING ME DÉJÀ VU , 17-48.
Onyeka, C. J. (2011). Journal of Commercial Biotechnology. Biotechnology commercialisation in universities of developing countries: A review of the University of Ibadan, Nigeria , 293-300.
Petetin, L. (2009). Environmental Law Review. Clone Wars? The Challenges of Cloned Food in EU, US and WTO Law , 246-263.
Riddle, J. A. (2007). Brown Journal of World Affairs. Brave New Beef: Animal Cloning and Its Impacts , 111-119.
Ukropcov, D. (201173-83). Journal of Commercial Biotechnology. Biotechnology commercialization: A case study from Central and Eastern Europe .
Vaughn, D. (2010). Marine Biology. Why run and hide when you can divide? Evidence for larval cloning and reduced larval size as an adaptive inducible defense , 1301-1312.
Wilmut, I. (2010). New Scientist Archive. CLONING , 48-49.
Yaacob, N. A. (2011). American Journal of Economics & Business Administration. Perceptions of Commercialization Activities of Research Results among Academic Researchers in Malaysia , 24-32.